Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: Efficacy, toxic effects, and limitations

Archives of Otolaryngology - Head and Neck Surgery

Volumn 130, Issue 7, 2004, Pages 861-867

  Hanna, Ehab ^a,b   Alexiou, Michael ^a   Morgan, Justin ^a   Badley, Jenny ^a   Maddox, Anne Marie ^a   Penagaricano, Jose ^a   Fan, Chun Yang ^a   Breau, Randall ^a   Suen, James ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGE; AGED; BONE NECROSIS; CANCER CHEMORADIOTHERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CARTILAGE DEGENERATION; COMORBIDITY; DEHYDRATION; DRUG FATALITY; DRUG RESPONSE; DYSPHAGIA; ELECTROLYTE DISTURBANCE; EVALUATION; FEMALE; FLUID THERAPY; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEAD AND NECK CANCER; HOSPITAL ADMISSION; HUMAN; HYPOPHARYNX CARCINOMA; LARYNX CARCINOMA; MALE; METASTASIS; MOUTH CARCINOMA; MUCOSA INFLAMMATION; NAUSEA; NEUTROPENIA; OROPHARYNX CARCINOMA; OUTCOMES RESEARCH; RADIATION NECROSIS; RETROSPECTIVE STUDY; REVIEW; SALVAGE THERAPY; SECOND CANCER; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TREATMENT FAILURE; UNITED STATES; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARKANSAS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; RADIOTHERAPY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 3142724878     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.130.7.861     Document Type: Review

References (21)

1. Wolf GT, Forastiere A, Ang K, et al. Workshop report: organ preservation strategies in advanced head and neck cancer: current status and future directions. Head Neck. 1999;21:689-693.
2. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer: the Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med. 1991;324:1685-1690.
3. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Coliette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial: EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst. 1996;88:890-899.
4. Adelstein DJ, Sharan VM, Earle AS, et al. Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer. Cancer. 1990;65:1685-1691.
5. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst. 1999;91:2081-2086.
6. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091-2098.
7. Pignon JP, Bourhis J, Domenge C, Designe L, MACH-NC Collaborative Group. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet. 2000;355:949-955.
8. Lee JH, Machtay M, Unger LD, et al. Prophylactic gastrostomy tubes in patients undergoing intensive irradiation for cancer of the head and neck. Arch Otolaryngol Head Neck Surg. 1998;124:871-875.
9. Lavertu P, Adelstein DJ, Saxton JP, et al. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer. Head Neck. 1997;19:559-566.
10. Mittal BB, Pauloski BR, Haraf DJ, et al. Swallowing dysfunction: preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review. Int J Radiat Oncol Biol Phys. 2003;57:1219-1230.
11. Pauloski BR, Rademaker AW, Logemann JA, Colangelo LA. Speech and swallowing in irradiated and nonirradiated postsurgical oral cancer patients. Otolaryngol Head Neck Surg. 1998;118:616-624.
12. Newman LA, Robbins KT, Logemann JA, et al. Swallowing and speech ability after treatment for head and neck cancer with targeted intraarterial versus intravenous chemoradiation. Head Neck. 2002;24:68-77.
13. Watkin KL, Diouf I, Gallagher TM, Logemann JA, Rademaker AW, Ettema SL. Ultrasonic quantification of geniohyoid cross-sectional area and tissue composition: a preliminary study of age and radiation effects. Head Neck. 2001;23:467-474.
14. Lazarus CL, Logemann JA, Pauloski BR, et al. Swallowing and tongue function following treatment for oral and oropharyngeal cancer. J Speech Lang Hear Res. 2000;43:1011-1023.
15. Hanna E, Cash D, Adams DC, Vural E, Fan CY, Sherman AC. Quality of life for patients following total laryngectomy versus chemoradiation for laryngeal preservation. Abstract presented at: American Head and Neck Society Annual Meeting; May 4-6, 2003; Nashville, Tenn.
16. Bradford CR, Wolf GT, Carey TE, et al. Predictive markers for response to chemotherapy, organ preservation, and survival in patients with advanced laryngeal carcinoma. Otolaryngol Head Neck Surg. 1999;121:534-538.
17. Costa A, Licitra L, Veneroni S, et al. Biological markers as indicators of pathological response to primary chemotherapy in oral-cavity cancers. Int J Cancer. 1998;79:619-623.
18. Koukourakis MI, Giatromanolaki A, Fountzilas G, Sivridis E, Gatter KC, Harris AL. Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy. Clin Cancer Res. 2000;6:381-389.
19. Vural E, Alexiou M, Hunt J, Korourian S, Hanna E. Is glutathione-S- transferase-pi expression a reliable predictor of chemoradiation response in cancer of the head and neck? Am J Otolaryngol. 2001;22:257-260.
20. Warnakulasuriya S, Jia C, Johnson N, Houghton J. p53 and P-glycoprotein expression are significant prognostic markers in advanced head and neck cancer treated with chemo/radiotherapy. J Pathol. 2000;191:33-38.
21. Hanna E, Shrieve DC, Ratanatharathorn V, et al. A novel alternative approach for prediction of radiation response of squamous cell carcinoma of head and neck. Cancer Res. 2001;61:2376-2380.